DNA Sequencing and Next-Generation Sequencing Market Would Grow at a CAGR of 17.45% by 2029

The universal DNA Sequencing and Next-Generation Sequencing market survey report makes available market data on the vendor landscape and a corresponding detailed analysis of the major vendors who are active in the market. This report comprises of a comprehensive evaluation of the market's growth prospects and restrictions. Market research analysis data covered in this report lend a hand to businesses for mapping strategies related to investment, revenue generation, production, product launches, costing, inventory, purchasing and marketing. In the world class DNA Sequencing and Next-Generation Sequencing report, market drivers, market restraints, opportunities, and challenges are also evaluated under market overview which provides useful insights to businesses for taking right steps.
Data Bridge Market Research analyses that the DNA sequencing and next-generation sequencing market which was USD 13.82 billion in 2021, would rocket up to USD 50.04 billion by 2029, and is expected to undergo a CAGR of 17.45% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Drivers

Increasing number of cancer cases
The increasing number of cancer cases around the world, rising research studies, increasing collaborations between research institutes and market players, as well as rising applications of DNA next generation sequencing and technological advancements in sequencing technologies, are all contributing to the growth of the DNA next generation sequencing market. The lack of experienced specialists, on the other hand, is likely to have a significant impact on the overall growth of the DNA next generation sequencing industry.

Rising R&D activities for developing novel next generation sequencing technologies
Over the forecast period, the need for next-generation sequencing methods will grow as R&D activities for treatments used in the treatment of genetic disorders increase. A substantial market demand will be created as R&D investments increase and the number of studies related to the treatment of genetic disorders among individuals grows. Governments in industrialised economies have implemented a number of programmes and laws to encourage scientists and researchers to explore treatments for chronic and rare diseases.

Increasing advantages of next generation sequencing techniques
In 2020, the academic institutes and research centres end-use category accounted for 45 percent of the market. Hospitals choose next-generation sequencing techniques because they can deliver clinical diagnosis in less time, which helps the market grow. In addition, next-generation sequencing can be utilised to collect the most up-to-date data and identify transmission links in order to avoid infections across hospital settings, which will boost market revenue.

Opportunities

The modifications and automation of this technique increased sequencing data while also helping researchers to better manage time, allowing them to attain important milestones in the Human Genome Project. Sequence-based gene expression analysis is now a "digital" alternative to analogue techniques. Genome sequencing has improved to the point where it is now simple and accurate. In the near future, these technical improvements are projected to enhance the size of the DNA next generation sequencing industry.
Access Full PDF Research Report: https://www.databridgemarketresearch.com/reports/global-dna-sequencing-and-next-generation-sequencing-market
Recent Development

In December 2020, Eurofins Genomics has released SARS-CoV-2 NGS services that are both cost-effective and optimised, allowing for entire viral genome sequencing.
In May 2020, Roche introduced the KAPA Target Enrichment portfolio and the KAPA HyperExome whole-exome research panel for target enrichment during sequencing.
Scope:

The DNA sequencing and next-generation sequencing market is segmented on the basis of product, type, technology, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

Instruments
Consumables
Services
Type

Whole genome sequencing
Exome sequencing
Targeted sequencing
Others
Application

Research application
Clinical application
Others
Technology

Sequencing by synthesis
Ion semiconductor sequencing
Others
End-user

Academic institutes and research centers
Hospitals and clinics
Pharmaceutical and biotechnology companies
Others
DNA Sequencing and Next-Generation Sequencing Market Regional Analysis/Insights
The DNA sequencing and next-generation sequencing market is analysed and market size insights and trends are provided by country, product, type, technology, application and end-user as referenced above.

The countries covered in the DNA sequencing and next-generation sequencing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market due to the presence of several clinical laboratories that use NGS to offer genetic testing services, which drives the regional market.

Asia-Pacific is expected to be the fastest-growing regional market from 2022 to 2029. The presence of local companies, such as BGI Genomics, and NGS service providers including First BASE Laboratories Sdn Bhd, Macrogen Asia-Pacific Pte Ltd., and others is expected to drive the market.

Some of the major players operating in the DNA sequencing and next-generation sequencing market are:

Illumina Inc. (U.S)
Thermo Fischer Scientific Inc. (U.S)
Oxford Nanopore Technologies plc (U.K)
Agilent Technologies, Inc. (U.S)
BGI (China)
PerkinElmer Inc. (U.S)
QIAGEN (Germany)
Eurofins Scientific (Luxembourg)
F. Hoffmann-La Roche Ltd (Switzerland)
Takara Bio Inc. (Japan)
GENEWIZ, Inc. (U.S)
Hamilton Company (U.S)
Macrogen Inc. (South Korea)
Zymo Research Corporation(U.S)
Tecan Trading AG (Switzerland)

Our Reports Will Help Clients Solve the Following Issues: -
Insecurity about the future:
Our research and insights help our clients anticipate upcoming revenue compartments and growth ranges. This will help our clients invest or divest their assets.
Understanding market opinions:
It is extremely vital to have an impartial understanding of market opinions for a strategy. Our insights provide a keen view on the market sentiment. We keep this reconnaissance by engaging with Key Opinion Leaders of a value chain of each industry we track.
Understanding the most reliable investment centers:
Our research ranks investment centers of market by considering their future demands, returns, and profit margins. Our clients can focus on most prominent investment centers by procuring our market research.
Evaluating potential business partners:
Our research and Insights help our clients identify compatible business partners.

Top Trending Reports by DBMR:

https://marketresearchnreports.blogspot.com/2023/05/acalculous-gallbladder-disease_30.html

https://marketresearchnreports.blogspot.com/2023/05/olliers-disease-market-trend-size.html

https://marketresearchnreports.blogspot.com/2023/05/goodpastures-syndrome-treatment-market_30.html

https://marketresearchnreports.blogspot.com/2023/05/mediastinal-mass-treatment-market_30.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
E-Mail: corporatesales@databridgemarketresearch.com

This release was published on openPR.